Lipid nanoparticles (LNPs) are biocompatible and biodegradable nanoparticles used for the delivery of therapeutic agents, such as drugs, RNA, and DNA. LNPs consist of a phospholipid bilayer that encapsulates a hydrophobic core made up of cholesterol and other lipids. The therapeutic agent is encapsulated within the core and delivered to the target site. LNPs have several advantages over other drug delivery systems. They are highly efficient in delivering hydrophobic drugs to target sites and can protect the drug from clearance by the immune system. They also have a high drug loading capacity, and the encapsulated drug is protected from degradation. The global lipid nanoparticles market size is projected to grow by USD 295.7 百万来自 2023 到 2029, 复合年增长率为 7.44 百分, 根据最新市场数据.

该行业报告提供了全球市场的市场预测, 接下来是对产品的详细分析, 应用, 和地区. The global market data on lipid nanoparticles can be segmented by product: mRNA-lipid nanoparticles, siRNA-lipid nanoparticles, 其他的. 据研究, the mRNA-lipid nanoparticles segment had the largest share in the global lipid nanoparticles market. Lipid nanoparticles market is further segmented by application: scientific research, vaccines and drugs. 在 2022, the vaccines and drugs segment made up the largest share of revenue generated by the lipid nanoparticles market. 根据地区, the lipid nanoparticles market is segmented into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. 在这些当中, 北美地区是全球收入最高的地区 2022.

The global lipid nanoparticles market is highly competitive. Key companies profiled in the report include Avanti Polar Lipids Inc., 赢创工业股份公司, Exelead Inc., Genevant Sciences GmbH, Lipoid GmbH, 默克公司, Nippon Fine Chemical Co. 有限公司, Precision NanoSystems Inc.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
• Get a detailed picture of the Global Lipid Nanoparticles Market
• Identify segments/areas to invest in over the forecast period in the Global Lipid Nanoparticles Market
• 了解竞争环境, 市场的领先参与者
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.